EU authorizes Novavax’s updated COVID vaccine targeting JN.1 strain
This content was published on
1 minute
(Reuters) – The European Union authorized Novavax’s updated COVID vaccine targeting the JN.1 strain of coronavirus, the company said on Wednesday.